Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus selected By ENV-CD4-CO-Receptor Complexes Read more about Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus selected By ENV-CD4-CO-Receptor Complexes India1073/CHEN/2004Filed on 2002-10-16
Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus Selected By ENV-CD4-CO-Receptor Complexes Read more about Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus Selected By ENV-CD4-CO-Receptor Complexes US Patent 7,223,844Filed on 2004-04-15
Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus Selected By ENV-CD4-CO-Receptor Complexes Read more about Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus Selected By ENV-CD4-CO-Receptor Complexes Canada2463931Filed on 2002-10-16
Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus selected By ENV-CD4-CO-Receptor Complexes Read more about Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus selected By ENV-CD4-CO-Receptor Complexes European Patent02773789.9Filed on 2000-10-16
Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus selected By ENV-CD4-CO-Receptor Complexes Read more about Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus selected By ENV-CD4-CO-Receptor Complexes Australia2002337885Filed on 2002-10-16
Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. Read more about Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. Canada2461351Filed on 2002-09-25
Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. Read more about Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. Australia2002327053Filed on 2002-09-25
Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. Read more about Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. European Patent02761818.0Filed on 2002-09-25
Mutuated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. Read more about Mutuated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. US Patent 7,355,012Filed on 2004-03-23
Hypoxia-Inducible Factor 1alpha Variants and Methods of Use Read more about Hypoxia-Inducible Factor 1alpha Variants and Methods of Use US Patent 7,193,053Filed on 2004-04-23